Market News

Senderra’s WellPath merges patient care and reliable outcomes data.
US Bioservices offers the clinical expertise and excellent patient care expected from an independent specialty pharmacy, combined with the stability and infrastructure of a global organization.
ExceleraRx Corp. announced a partnership with Smith & Nephew for advanced wound care management products used in the treatment of acute and chronic wounds. These products will be made available through Excelera to health system specialty pharmacies.
Dallas-based Senderra Rx achieves perfect net promoter score.
The U.S. Food and Drug Administration approved NERLYNX (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer in July 2017.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$